SAN DIEGO and ADELAIDE, Australia, June 13, 2022 /PRNewswire/ — BioCina, a leading contract development and manufacturing organization (CDMO) today announced that the company has expanded its CDMO service offering to include the manufacture of plasmid DNA (pDNA) in a new dedicated GMP…
Related Posts
GALIANO GOLD PROVIDES METALLURGICAL AND OPERATIONAL UPDATE AT ASANKO GOLD MINE
(All dollar amounts are United States dollars unless otherwise stated) VANCOUVER, BC, July 8, 2022 /PRNewswire/ – Galiano Gold Inc.…
Growing At 5.4% CAGR, Architectural Coatings Market to hit USD 99.56 Billion in 2028, Says Brandessence Market Research
LONDON, July 11, 2022 /PRNewswire/ — Global Architectural Coatings Market is valued at USD 68.90 Billion in 2021 and is…
Uranium Royalty Corp. Files Annual Report
VANCOUVER, BC, July 27, 2022 /PRNewswire/ – Uranium Royalty Corp. (NASDAQ: UROY) (TSXV: URC) (“URC” or the “Company”) announces that…